IRIS
PATTI, Giuseppe Rocco Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.985
EU - Europa 2.062
AS - Asia 1.137
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
SA - Sud America 2
AF - Africa 1
Totale 7.197
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.983
IE - Irlanda 1.141
CN - Cina 758
UA - Ucraina 376
DE - Germania 353
TR - Turchia 317
IT - Italia 96
IN - India 54
FR - Francia 41
SE - Svezia 18
BE - Belgio 13
FI - Finlandia 8
SG - Singapore 6
EU - Europa 5
NL - Olanda 4
AU - Australia 3
GB - Regno Unito 3
RU - Federazione Russa 3
BR - Brasile 2
ES - Italia 2
NZ - Nuova Zelanda 2
AT - Austria 1
BG - Bulgaria 1
CA - Canada 1
EG - Egitto 1
HU - Ungheria 1
IL - Israele 1
MX - Messico 1
NO - Norvegia 1
PK - Pakistan 1
Totale 7.197
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.488
Dublin 1.139
Chandler 821
Izmir 317
Nanjing 312
Lawrence 189
Princeton 189
Wilmington 130
Nanchang 103
L'aquila 85
Ashburn 84
New York 82
Pune 53
Shenyang 51
Hebei 42
Tianjin 40
Jiaxing 31
San Mateo 30
Kunming 29
Norwalk 29
Changsha 25
Beijing 23
Ann Arbor 20
Jinan 19
Los Angeles 19
Lanzhou 17
Mountain View 15
Shanghai 15
Brussels 13
Changchun 10
Zhengzhou 10
Ningbo 9
Des Moines 7
Fremont 5
Hangzhou 5
Redwood City 5
Singapore 5
Boardman 4
Helsinki 4
Lappeenranta 4
Phoenix 4
Dearborn 3
Fuzhou 3
Orange 3
Seattle 3
Tomsk 3
Bremen 2
Fairfield 2
Frankfurt am Main 2
Guangzhou 2
Menlo Park 2
Milan 2
Novara 2
Santa Clara 2
Taiyuan 2
Taizhou 2
Amsterdam 1
Aquila 1
Auckland 1
Avigliano 1
Barcelona 1
Belo Horizonte 1
Berlin 1
Budapest 1
Christchurch 1
Cuauhtémoc 1
Edinburgh 1
Ercolano 1
Fabbrico 1
Forest City 1
Haikou 1
Hanover 1
Hefei 1
Houston 1
Laurel 1
Madrid 1
Melbourne 1
Monaghan 1
Oslo 1
Paris 1
Porto Alegre 1
Redmond 1
Rome 1
San Diego 1
Sofia 1
Stockholm 1
Strasbourg 1
Sydney 1
Tel Aviv 1
Toronto 1
Vienna 1
Wazirabad 1
York 1
Totale 5.554
Salva come PNG Salva come JPEG
Nome #
Author`s Reply 69
Comparability of efficacy and safety results among phase III trials of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation 59
Aggiornamenti in tema di terapia antitrombotica dopo chiusura percutanea dell’auricola sinistra 58
Capitolo "La chiusura dell’auricola nella prevenzione dell’ictus: siamo sicuri che serve?" per il libro edito da A. Ciolli, A. B. Scardovi, M. Ciavolella, M. Uguccioni) (Casa Editrice Scientifica Internazionale) 57
Strategies of clopidogrel load and atorvastatin reload to prevent ischemic cerebral events in patients undergoing protected carotid stenting. Results of the randomized ARMYDA-9 CAROTID (Clopidogrel and Atorvastatin Treatment During Carotid Artery Stenting) study 56
Safety and Efficacy of Switching From Clopidogrel to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: A Study-level Meta-analysis From 15 Studies. 56
Intermittent warm blood cardioplegia induces the expression of heat shock protein-72 by ischemic myocardial preconditioning 55
Effects of atorvastatin on systemic inflammatory response after coronary bypass surgery 55
Atorvastatin for reduction of myocardial damage during angioplasty trials 54
Patients with atrial fibrillation and CHA2DS2-VASc score 1: "To anticoagulate or not to anticoagulate? That is the question! 54
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry. 53
Comparison among patients ≥75 years having percutaneous coronary angioplasty using drug-eluting stents versus bare metal stents 53
Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention 51
Switching of platelet P2Y12 receptor inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention: Review of the literature and practical considerations 50
Short-Term, High-Dose Atorvastatin Pretreatment to Prevent Contrast-Induced Nephropathy in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the ARMYDA-CIN [Atorvastatin for Reduction of MYocardial Damage during Angioplasty Contrast-Induced Nephropathy] Trial 50
Long-Term Prognosis and Outcome Predictors in Takotsubo Syndrome: A Systematic Review and Meta-Regression Study 50
Meta-Analysis Comparing the Safety and Efficacy of Dual Versus Triple Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention 50
Myocardial infarction during pregnancy and postpartum: A review 50
A Therapeutic Window for Platelet Reactivity for Patients Undergoing Elective Percutaneous Coronary Intervention Results of the ARMYDA-PROVE (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity for Outcome Validation Effort) Study 49
Are we ready for a gender-specific approach in interventional cardiology? 49
Hand-held echocardiography in the setting of pre-operative cardiac evaluation of patients undergoing non-cardiac surgery: results from a randomized pilot study 48
Early and long-term results of stenting of diffuse coronary artery disease 48
Comparison of the Feasibility and Effectiveness of Transradial Coronary Angiography Via Right Versus Left Radial Artery Approaches (from the PREVAIL Study) 48
Antithrombotic therapy in patients with acute coronary syndromes: a balance between protection from ischemic events and risk of bleeding 48
Standard- vs High-Dose Clopidogrel After Percutaneous Coronary Intervention 48
The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly 48
Intracardiac Versus Transesophageal Echocardiographic Guidance for Left Atrial Appendage Occlusion: The LAAO Italian Multicenter Registry 48
Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects 48
Antibiotic prophylaxis and treatment of cardiovascular disease - Response 47
Antiplatelet therapy in patients with diabetes mellitus and acute coronary syndrome 47
Chapter “Urgent surgery early after percutaneous coronary intervention in a patient with atrial fibrillation on triple therapy of non-vitamin K antagonist oral anticoagulant, aspirin and clopidogrel” for the book “Atrial fibrillation and percutaneous coronary intervention – A case-based guide to oral anticoagulation, antiplatelet therapy and stenting” (Editors A. Rubboli, G.Y.H. Lip) (Springer) 47
Have statins beneficial anti-inflammatory as well as lipid-lowering effects 47
Meta-analysis of net long-term benefit of different therapeutic strategies in patients with cryptogenic stroke and patent foramen ovale 47
Usefulness of preprocedural levels of advanced glycation end products to predict restenosis in patients with controlled diabetes mellitus undergoing drug-eluting stent implantation for stable angina pectoris (from the Prospective ARMYDA-AGEs Study) 46
Atorvastatin pretreatment in early percutaneous coronary intervention 46
Antithrombotic Strategies in Patients on Oral Anticoagulant Therapy Undergoing Percutaneous Coronary Intervention: A Proposed Algorithm Based on Individual Risk Stratification 46
Meta-Analysis Comparison (Nine Trials) of Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in Patients With Diabetes Mellitus 45
Effect of High-Dose Atorvastatin Reload on the Release of Endothelial Progenitor Cells in Patients on Long-Term Statin Treatment Who Underwent Percutaneous Coronary Intervention (from the ARMYDA-EPC Study) 45
Prasugrel versus clopidogrel 45
Percutaneous Left Atrial Appendage Closure: Acute Effects on Left Atrial Pressure in Humans 45
Italian intersocietary consensus document on aspirin therapy in primary cardiovascular prevention 45
Untitled 44
Effects of cigarette smoking on platelet reactivity during P2Y12 inhibition in patients with myocardial infarction undergoing drug-eluting stent implantation: results from the prospective cigarette smoking on platelet reactivity (COPTER) study 44
Prevalence and predictors of dual antiplatelet therapy prolongation beyond one year in patients with acute coronary syndrome 44
Apoptosis and post-infarction left ventricular remodeling 44
Impact of Chronic Renal Failure on Ischemic and Bleeding Events at 1 Year in Patients With Acute Coronary Syndrome (from the Multicenter START ANTIPLATELET Registry) 44
Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy 44
Simvastatin reduces platelet-endocardium adhesion in atrial fibrillation 44
Complete Revascularization During Primary Percutaneous Coronary Intervention Reduces Death and Myocardial Infarction in Patients With Multivessel Disease: Meta-Analysis and Meta-Regression of Randomized Trials 44
Impact of SARS-CoV-2 Outbreak on Emergency Department Presentation and Prognosis of Patients with Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis 44
Pretreatment with different loading doses of clopidogrel influences P-selectin levels in patients undergoing percutaneous coronary intervention: results from the ARMYDA-2 (antiplatelet therapy for reduction of myocardial damage during angioplasty) SELECT substudy 43
Left atrial appendage closure using AMPLATZER™ devices: A large, multicenter, Italian Registry 43
Apoptosis in recent myocardial infarction 43
Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies 43
Intracardiac echocardiography with ultrasound probe placed in the upper left pulmonary vein to guide left atrial appendage closure: First description 43
Efficacy and safety of mineralocorticoid receptors in mild to moderate arterial hypertension 42
Antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting: Suggested strategies tailored to an integrated evaluation of different risk profiles 42
Secondary cardiovascular prevention after acute coronary syndrome in clinical practice 42
Changing features of anginal pain after PTCA suggest a stenosis on a different artery rather than restenosis 42
Endothelial and cardiac progenitor cells for cardiovascular repair: A controversial paradigm in cell therapy 42
Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis 42
Prognostic role of preprocedural glucose levels on short- and long-term outcome in patients undergoing percutaneous coronary revascularization 42
Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention 42
Psychological stress as precipitating factor of the acute manifestations of ischemic cardiopathy 41
Impact of chronic kidney disease on platelet reactivity and outcomes of patients receiving clopidogrel and undergoing percutaneous coronary intervention 41
Circadian distribution of ischemic attacks and ischemia-related ventricular arrhythmias in patients with variant angina 41
Prevention of myocardial damage during coronary intervention 41
Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: The prospective, multicentre observational PREvention of thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF) 41
Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs 41
Comparison of Lipid-Lowering Medications and Risk for Cardiovascular Disease in Diabetes 41
Intracardiac Versus Transesophageal Echocardiography for Assisting Percutaneous Left Atrial Appendage Occlusion?: “Veni, vidi, vICE”! 41
Combining Antiplatelet and Anticoagulant Therapies 41
Dissecting intramyocardial hematoma masquerading as a pseudoaneurysm of left ventricular free wall: An unusual case of myocardial rupture 41
Giant left ventricular pseudoaneurysm complicating an acute myocardial infarction in patient with previous cardiac surgery: a case report 40
The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences 40
Association of virulent Helicobacter pylori strains with ischemic heart disease 40
Preconditioning by transient myocardial ischemia confers protection against ischemia-induced ventricular arrhythmias in variant angina 40
Key references: Basic fibrinolysis and thrombolysis selected references: 1987-1997 40
Safety and efficacy of non-vitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials 40
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study 40
Percutaneous coronary interventions and statin therapy 40
Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: A prospective single-center registry in high-risk patients 40
Efficacy of clopidogrel reloading in patients with acute coronary syndrome undergoing percutaneous coronary intervention during chronic clopidogrel therapy (from the Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty [ARMYDA-8 RELOAD-ACS] trial) 40
Editorial: Short-term high-dose atorvastatin for periprocedural myocardial infarction prevention in patients with renal dysfunction 40
Gender-Related Differences in Antiplatelet Therapy and Impact on 1-Year Clinical Outcome in Patients Presenting With ACS: The START ANTIPLATELET Registry 40
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper 40
Cardiogenic Shock Following Acute Myocardial Infarction: What's New? 40
Improvement of myocardial ischemia by subclavian stent implantation in patients with internal mammary grafts: A case report and review of the literature 40
Coronary stenting in patients with depressed left ventricular function: Acute and long-term results in a selected population 39
Platelets GP-IIB-IIA receptor inhibitors in ischemic patients 39
Virulent strains of Helicobacter pylori and vascular diseases: A meta-analysis 39
Inflammatory markers and coronary interventions: A potentially useful follow-up modality after stenting 39
Thromboembolic Risk, Bleeding Outcomes and Effect of Different Antithrombotic Strategies in Very Elderly Patients With Atrial Fibrillation: A Sub-Analysis From the PREFER in AF (PREvention oF Thromboembolic Events-European Registry in Atrial Fibrillation) 39
De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis 39
Efficacy and safety of oral anticoagulant therapy in frail patients with atrial fibrillation 39
Net clinical benefit of patent foramen ovale closure in patients with cryptogenic stroke: Meta-analysis and meta-regression of randomized trials 39
Statin loading for acute coronary syndromes 39
Meta-analysis of clinical trials on use of drug-eluting stents for treatment of acute myocardial infarction 39
Patients with atrial fibrillation and coronary events: Are we any closer to coming out from the labyrinth of the various antithrombotic strategies? 39
Meta-analysis: High-dose statin pretreatment prevents periprocedural cardiac events in patients having PCI 39
Totale 4.485
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.427 372 6 193 1 1 191 263 3 207 2 0 188
2020/20211.176 8 193 3 189 190 1 198 1 176 1 216 0
2021/2022509 1 0 5 5 15 3 9 61 68 5 84 253
2022/20232.682 218 87 46 211 196 239 0 159 1.387 11 78 50
2023/2024483 98 25 31 22 39 192 2 39 0 24 2 9
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 7.419